A historic quantum computing milestone has lifted IBM shares, yet the market remains oddly restrained on the broader transformation story....

Amazon is drawing a line under one of the earliest pillars of its artificial intelligence strategy. The company will stop...

As Germany’s summer holidays start on July 6, a wave of major construction projects is rolling out across Saxony and...

Antimony Resources finds itself at a crossroads. A fresh gold discovery at its Bald Hill project in New Brunswick has...

Ocugen has quietly reshaped its financial outlook. In May, the company placed $130 million in convertible notes, carrying a 6.75%...

The euphoria over memory chips has drawn two distinctly unwelcome guests to the party. Michael Burry, the investor famous for...

Nvidia is no longer content with simply selling chips. The company is rewriting its revenue playbook, moving from upfront hardware...

Just five days after a landmark Supreme Court victory, Bayer has opened a second front in its glyphosate saga —...

The antimony market has been anything but ordinary since Beijing imposed export restrictions on the critical mineral, sending prices hurtling...

July is shaping up as a binary-riddled month for the small-cap biopharma. Two weeks after shareholders cast decisive ballots on...